-1.90%
Today
Loading 1D prices…
Company profile
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Taipei, United States
Employees
14
Fiscal year end
1231
CIK
2070534
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ODTXOdyssey Therapeutics Inc. Common Stock | $1.2B | $3M | -4994.86% | -$5.39 | +4.19% | Buy |
| GLUEMonte Rosa Therapeutics Inc. Common Stock | $1.2B | $123.7M | -31.21% | -$0.5893 | -1.75% | Buy |
| REPLReplimune Group Inc. Common Stock | $1.2B | $0.00 | — | -$3.38 | -2.34% | Buy |
| MGTXMeiraGTx Holdings plc Ordinary Shares | $1.2B | $81.4M | -140.31% | -$1.42 | -0.43% | Buy |
| CGEMCullinan Therapeutics Inc. Common Stock | $1.3B | $0.00 | — | -$3.36 | -2.05% | Buy |